The GHI started working on the development of The Lancet Oncology Commission Report on Sustainable Pediatric Cancer Care in 2015 under the leadership of Dr. Carlos Rodriguez-Galindo. The Report core team includes the following chairs and co-chairs, as well as a number of pediatric oncology leaders from more than 15 low- and mid-income countries (LMIC).
The report is expected to be published in early 2019 and will include an estimate of the current burden of childhood cancer (incidence and survival), an assessment of the current level of access to care, guidelines for the tiered development of pediatric cancer care, and the return on investment in terms of lives saved and economic benefit if pediatric cancer care were scaled up to various degrees between now and 2030. This report draws upon qualitative and quantitative work from experts from across the globe, drawing upon experts in health systems, public health, delivery of pediatric cancer care, epidemiology and cost-effectiveness. Highlights from the report were presented at SIOP in Kyoto, Japan in November 2018.
Lindsay Frazier, MD, ScM, participated in the inaugural meeting for the Pediatric Oncology Roundtable to Transform Access to Global Essentials (PORTAGE) Initiative in Essential Medicines in Sharjah, United Arab Emirates in January 2018 to discuss ways in which to enhance access to cancer medicines for children in LMIC. Represented at the table were pharmaceutical companies, WHO and World Bank, NGOs such as the Clinton Health Access Initiative, medicines experts and global health practitioners. The goal of the group is to orchestrate sustainable solutions such as better drug forecasting needs, pooled procurement, and uniform quality assessment of generic medications.
Contact us to learn how you can support our Global Health Initiative.
Help others learn about our Global Health Initiative (GHI). Download and share our brochure.